Qnexa

Obesity And The FDA: Why Qnexa Is Generating Buzz
Seeking Alpha
Thu, 03/22/12 - 05:35 pm
FDA
obesity
Qnexa
A Picture is Worth a Thousand Words: The Difference Between "Yes" and "No" During an FDA Advisory Committee
Elsevier Business
Fri, 03/9/12 - 10:49 am
FDA
advisory panels
Xgeva
Amgen
Vivus
Qnexa
Arena Pharmaceuticals' Lorcaserin Will Be A Blockbuster Drug
Seeking Alpha
Wed, 02/29/12 - 11:04 am
Arena Pharmaceuticals
lorcaserin
Vivus
Qnexa
obesity
Obesity Epidemic Prompting Vivus Takeover Talk With 68% Windfall: Real M&A
Bloomberg
Wed, 02/29/12 - 10:12 am
obesity
M&A
Vivus
Qnexa
JNJ
Merck
Bristol-Myers Squibb
Arena Pharmaceuticals
Orexigen
Vivus's Qnexa And Its Potential Value
Seeking Alpha
Sat, 02/25/12 - 09:23 am
Vivus
Qnexa
obesity
weight loss
Vivus Drug Won't Solve U.S. Weight Woes, Says Author (video)
The Street
Sat, 02/25/12 - 09:14 am
Vivus
Qnexa
How Qnexa's Positive Panel Review Generated Alpha For Short Sellers
Seeking Alpha
Fri, 02/24/12 - 09:59 am
Qnexa
Vivus
obesity
Arena Pharmaceuticals
Orexigen
Vivus rockets 99% on FDA nod
Marketwatch
Thu, 02/23/12 - 10:41 am
FDA
Vivus
obesity
Qnexa
FDA panel overwhelmingly backs previously rejected anti-obesity pill Qnexa
Washington Post, DC
Wed, 02/22/12 - 10:12 pm
FDA
Vivus
obesity
Qnexa
advisory panel
Vivus: FDA Panel Live Blog
TheStreet.com
Wed, 02/22/12 - 08:08 am
FDA
Vivus
obesity
advisory panel
Qnexa
Opportunity In The Weight Loss Drug Market
Seeking Alpha
Tue, 02/21/12 - 07:19 pm
obesity
Vivus
Qnexa
Abbott Laboratories
Alkermes
GSK
JNJ
Roche
Orexigen
A Negative Vote for Vivus Obesity Drug, Says 'FDA Panel Whisperer'
TheStreet.com
Tue, 02/21/12 - 10:44 am
obesity
Vivus
advisory panel
FDA
Qnexa
No Way? Obesity Drugs Have Side Effects
Motley Fool
Sat, 02/18/12 - 12:11 pm
Vivus
obesity
Qnexa
Orexigen
Contrave
Arena Pharmaceuticals
Vivus obesity drug has safety risks-US FDA staff
Reuters
Fri, 02/17/12 - 09:12 am
Vivus
obesity
FDA
Qnexa
The Skinny on Upcoming Obesity FDA Meetings
Motley Fool
Sat, 02/11/12 - 11:44 am
Vivus
Qnexa
Arena Pharmaceuticals
lorcaserin
pixantrone
Cell Therapeutics
obesity
weight loss
FDA Pharma Meetings for February
Motley Fool
Tue, 01/31/12 - 07:58 am
FDA
Amgen
Xgeva
Cell Therapeutics
Pixuvri
Vivus
Qnexa
Chelsea Therapeutics
Northera
Diet Pill Scorecard: Vivus, Arena, Orexigen Still Chasing Market Approvals
Minyanville
Fri, 01/13/12 - 10:26 am
Vivus
Arena
Orexigen
obesity
lorcaserin
Qnexa
Contrave
Vivus obesity drug may get broader label
Reuters
Mon, 01/9/12 - 10:30 am
obesity
Vivus
Qnexa
FDA panel to review Qnexa in February 2012
Drug Store News
Fri, 12/23/11 - 08:59 am
FDA
advisory panels
obesity
Qnexa
Vivus
Vivus falls 15% on drug safety study
Marketwatch
Thu, 12/22/11 - 02:44 pm
Vivus
Qnexa

Pages